Lexent Bio developed novel liquid biopsy technology to diagnose and treat cancer. Acquired by Foundation Medicine in June 2020.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountUnknown
Create a free account to see which investors have funded this company.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
